{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":17,"n_cols":5,"rows_kept":17,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910880293603321"]
[null,null,"Autore",null,"Berger Stephen"]
[null,null,"Titolo",null,"Varicella-Zoster"]
[null,null,"Pubbl/distr/stampa",null,"Los Angeles : , : Gideon Informatics, Incorporated, , 2024"]
[{"$nulls":4},"©2024"]
[null,null,"ISBN",null,"1-4988-4660-2"]
[null,null,"Edizione",null,"[2024th ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (249 pages)"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Herpes zoster -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccine -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- American Samoa -- Australia -- References -- The Bahamas -- Belgium -- References -- Benin -- References -- Bolivia -- References -- Bosnia and Herzegovina -- Brazil -- References -- Cameroon -- References -- Canada -- References -- China -- References -- Colombia -- References -- The Czech Republic -- References -- Denmark -- References -- Egypt -- References -- France -- References -- Gabon -- References -- Germany -- References -- Guam -- India -- References -- Indonesia -- References -- Iran -- References -- Ireland -- Israel -- References -- Italy -- References -- Japan -- References -- Kuwait -- Madagascar -- References -- Malta -- Montenegro -- The Netherlands -- References -- New Zealand -- References -- Nigeria -- References -- The Northern Marianas -- Oman -- Paraguay -- Poland -- References -- Portugal -- References -- Puerto Rico -- South Korea -- References -- The Russian Federation -- References -- Saudi Arabia -- References -- Scotland -- Sierra Leone -- References -- Slovenia -- Spain -- References -- Sri Lanka -- References -- Saint Kitts and Nevis -- Sweden -- References -- Taiwan -- References -- Thailand -- References -- Trinidad and Tobago -- Turkey -- References -- The United Kingdom -- References -- The United States -- References -- The U.S. Virgin Islands -- Varicella -- Epidemiology "]
[{"$nulls":4},"-- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccine."]
[{"$nulls":4},"Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Afghanistan -- References -- Albania -- Algeria -- References -- American Samoa -- References -- Andorra -- Anguilla -- Antigua and Barbuda -- References -- The Antilles (miscellaneous) -- References -- Argentina -- References -- Armenia -- References -- Aruba -- Australia -- References -- Austria -- References -- Azerbaijan -- The Bahamas -- References -- Bahrain -- Bangladesh -- References -- Barbados -- References -- Belarus -- Belgium -- References -- Belize -- Bermuda -- References -- Bhutan -- References -- Bolivia -- References -- Bosnia and Herzegovina -- Brazil -- References -- The British Virgin Islands -- Brunei -- Bulgaria -- Burundi -- References -- Canada -- References -- The Canary Islands -- References -- Cape Verde -- The Cayman Islands -- References -- Central African Republic -- References -- Chile -- References -- China -- References -- Colombia -- References -- Congo -- References -- The Cook Islands -- Costa Rica -- References -- Croatia -- References -- Cuba -- Cyprus -- The Czech Republic -- References -- The Democratic Republic of Congo -- References -- Denmark -- References -- Dominica -- The Dominican Republic -- Ecuador -- References -- Egypt -- References -- El Salvador -- Eritrea -- References -- Estonia -- Finland -- References -- France -- References -- French Guiana -- References -- French Polynesia -- Georgia -- References -- Germany -- References -- Ghana -- References -- Greece -- References -- Grenada -- References -- Guadeloupe -- References -- Guam -- Guatemala -- References -- Guinea -- References -- Guinea Bissau -- References -- Guyana -- References -- Honduras -- Hong Kong -- References -- Hungary -- Iceland -- References -- India -- References -- Indonesia -- References -- Iran."]
[{"$nulls":4},"References -- Iraq -- References -- Ireland -- References -- Israel -- References -- Italy -- References -- Ivory Coast -- References -- Jamaica -- References -- Japan -- References -- Jordan -- References -- Kazakhstan -- References -- Kenya -- References -- Kosovo -- References -- Kuwait -- References -- Laos -- References -- Latvia -- Lebanon -- References -- Liberia -- Liechtenstein -- Lithuania -- Luxembourg -- References -- Macao -- Malaysia -- References -- The Maldives -- References -- Malta -- The Marshall Islands -- Martinique -- Mexico -- References -- Micronesia -- References -- Moldova -- Mongolia -- Montenegro -- References -- Montserrat -- Morocco -- References -- Myanmar -- References -- Nepal -- References -- The Netherlands -- References -- New Zealand -- References -- Nigeria -- References -- Niue -- North Macedonia -- Northern Ireland -- The Northern Marianas -- Norway -- References -- Oman -- Pakistan -- References -- Palau -- Panama -- References -- Paraguay -- References -- Peru -- References -- The Philippines -- References -- Poland -- References -- Portugal -- References -- Puerto Rico -- References -- Qatar -- References -- South Korea -- References -- Reunion -- Romania -- References -- The Russian Federation -- References -- San Marino -- Saudi Arabia -- References -- Scotland -- References -- Senegal -- References -- Serbia -- References -- The Seychelles -- Singapore -- References -- Slovakia -- Slovenia -- References -- Somalia -- References -- South Africa -- References -- South Sudan -- References -- Spain -- References -- Sri Lanka -- References -- Saint Kitts and Nevis -- Saint Lucia -- References -- Saint Vincent and The Grenadines -- Sudan -- References -- Suriname "]
[{"$nulls":4},"-- References -- Sweden -- References -- Switzerland -- References -- Syria -- References -- Taiwan -- References -- Tajikistan -- Thailand."]
[{"$nulls":4},"References -- Trinidad and Tobago -- Tunisia -- References -- Turkey -- References -- Turkmenistan -- The Turks and Caicos Islands -- References -- Uganda -- References -- Ukraine -- References -- The United Arab Emirates -- References -- The United Kingdom -- References -- The United States -- References -- Uruguay -- References -- Uzbekistan -- Venezuela -- References -- Vietnam -- References -- The U.S. Virgin Islands -- References -- Zambia -- References -- Vaccines &amp -- Immunoglobulins -- Herpes zoster - live vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Herpes zoster - live vaccine (6 listed) -- Contraindications for Herpes zoster - live vaccine (7 listed) -- Trade names of Herpes zoster - live vaccine (1 listed) -- Varicella vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Varicella vaccine (20 listed) -- Contraindications for Varicella vaccine (9 listed) -- Trade names of Varicella vaccine (13 listed) -- Varicella-Zoster immune globulin -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Varicella-Zoster immune globulin (4 listed) -- Contraindications for Varicella-Zoster immune globulin (2 listed) -- Trade names of Varicella-Zoster immune globulin (13 listed) -- About GIDEON."]